A new modified version of the SARS-CoV-2 spike protein has a 10-fold higher expression rate in cell cultures than an earlier version that forms the basis of some candidates currently in clinical trials. Vaccine manufacturers could swap in the new version and produce vaccine doses at much higher rates, researchers say.
COVID-19 vaccine innovation could dramatically speed up worldwide production
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024
About admin
Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge.
Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →